Enrolling Dogs With Stifle or Hip Osteoarthritis on a Study Involving LIBRELA

Principle Investigator

Masataka Enomoto, B. Duncan X. Lascelles

Description

Translational Research in Pain team is seeking dogs with osteoarthritis to take part in a
study aiming to compare the efficacy of two FDA-approved medications. We will do this
using computerized analysis of gait. Enrolled dogs will all receive one of the FDA
approved drugs. (Half of the dogs will receive newly FDA-approved medication, Librela)

Eligibility

To be eligible for the study, your dog must meet the following requirements:

• Weight ≥ 20 kgs
• Is ≥ 1 year of age
• Limping in at least one of the back legs due to osteoarthritis in knee and/or hip
joints
• Stop the administration of non-steroidal anti-inflammatories (NSAIDs, e.g.
‘Rimadyl’) for 7 consecutive days prior to the screening visit
• Be healthy enough to receive sedation for x-rays

Testing Requirements

• Owners will be required to come to NCSU with their dog for a total of 6 study
visits over the course of 2.5 months
• Give daily oral medication

Benefits (*)

• FREE physical, orthopedic, and neurological exam
• FREE bloodwork and urine analysis
• X-ray of all joints
• $100 Gift Card with study completion
• All dogs receive approved medication
(* for dogs that do not qualify, only examinations and bloodwork will be performed)

Enrollment Start

Oct 2023

Enrollment Finish

Sept 2024 (completed)

Flyer

View

Questionnaire

Thank you very much for your interest in our clinical trial. The goal number of participants has been reached and recruitment/enrollment has been closed.

Contact

For additional information, please contact our specialist research team: 919-513-6853 or
rmtomach@ncsu.edu.